Artal Group, 10% Owner: Crescent Biopharma CBIO Buy · Filed 23/02/17

Trade details

Type: Insider buy
Amount: $529,646.88
Shares · price: 315,266 sh · $1.68 a share
Held after: 7,889,064 sh
Stock: Crescent Biopharma CBIO
Person: Artal Group10% Owner
Trade date: 23/02/16
Filed: 23/02/17
Days to filing: 1 days

8 insiders bought this week

Insiders buying this week: 8 insiders
Holding change: +4.2%

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 23/01/17~23/03/18

Artal Group's recent trades

Artal GroupDirector
SellCava Group
Sell
Cava Group
CAVA
$270.9M
3,000,000 sh
$270.9M
Filed 06/17
Traded 06/15
Artal GroupDirector
BuyLexicon Pharmaceuticals
Buy
Lexicon Pharmaceuticals
LXRX
$2M
1,538,462 sh
$2M
Filed 02/04
Traded 02/02
Artal GroupDirector
SellCava Group
Sell
Cava Group
CAVA
$1.1B
8,000,000 sh
$1.1B
Filed 24/11/20
Traded 24/11/18
Artal GroupDirector
SellCava Group
Sell
Cava Group
CAVA
$698.2M
6,000,000 sh
$698.2M
Filed 24/08/28
Traded 24/08/26
Artal GroupDirector
SellCava Group
Sell
Cava Group
CAVA
$261.8M
3,000,000 sh
$261.8M
Filed 24/06/07
Traded 24/06/05

Artal Group, 10% Owner — bought $529.6K of Crescent Biopharma CBIO · 315,266 sh @ $1.68 | Whalegun